1.
Ball J, Carrington MJ, McMurray JJ, Stewart S: Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century. Int J Cardiol 2013, 167(5):1807-1824.
2.
Gupta K, Pillarisetti J, Biria M, Pescetto M, Abu-Salah TM, Annapureddy C, Ryschon
K, Dawn B, Lakkireddy D: Clinical utility and prognostic significance of measuring troponin I levels in patients
presenting to the emergency room with atrial fibrillation. Clin Cardiol 2014, 37(6):343-349.
3.
van den Bos EJ, Constantinescu AA, van Domburg RT, Akin S, Jordaens LJ, Kofflard MJ:
Minor elevations in troponin I are associated with mortality and adverse cardiac events
in patients with atrial fibrillation. Eur Heart J 2011, 32(5):611-617.
4.
Reichlin T, Hochholzer W, Bassetti S, Steuer S, Stelzig C, Hartwiger S, Biedert S,
Schaub N, Buerge C, Potocki M et al: Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009, 361(9):858-867.
5.
Keller T, Zeller T, Peetz D, Tzikas S, Roth A, Czyz E, Bickel C, Baldus S, Warnholtz
A, Frohlich M et al: Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009, 361(9):868-877.
6.
Hoff J, Wehner W, Nambi V: Troponin in Cardiovascular Disease Prevention: Updates and Future Direction. Curr Atheroscler Rep 2016, 18(3):12.
7.
Agewall S, Giannitsis E, Jernberg T, Katus H: Troponin elevation in coronary vs. non-coronary disease. Eur Heart J 2011, 32(4):404-411.
8.
Weijs B, Pisters R, Haest RJ, Kragten JA, Joosen IA, Versteylen M, Timmermans CC,
Pison L, Blaauw Y, Hofstra L et al: Patients originally diagnosed with idiopathic atrial fibrillation more often suffer
from insidious coronary artery disease compared to healthy sinus rhythm controls. Heart Rhythm 2012, 9(12):1923-1929.
9.
Nucifora G, Schuijf JD, van Werkhoven JM, Trines SA, Kajander S, Tops LF, Turta O,
Jukema JW, Schreur JH, Heijenbrok MW et al: Relationship between obstructive coronary artery disease and abnormal stress testing
in patients with paroxysmal or persistent atrial fibrillation. Int J Cardiovasc Imaging 2011, 27(6):777-785.
10.
Soliman EZ, Safford MM, Muntner P, Khodneva Y, Dawood FZ, Zakai NA, Thacker EL, Judd
S, Howard VJ, Howard G et al: Atrial fibrillation and the risk of myocardial infarction. JAMA Intern Med 2014, 174(1):107-114.
11.
Hansen CL, Goldstein RA, Akinboboye OO, Berman DS, Botvinick EH, Churchwell KB, Cooke
CD, Corbett JR, Cullom SJ, Dahlberg ST et al: Myocardial perfusion and function: single photon emission computed tomography. J Nucl Cardiol 2007, 14(6):e39-60.
12.
Thygesen K, Mair J, Giannitsis E, Mueller C, Lindahl B, Blankenberg S, Huber K, Plebani
M, Biasucci LM, Tubaro M et al: How to use high-sensitivity cardiac troponins in acute cardiac care. Eur Heart J 2012, 33(18):2252-2257.
13.
Fletcher GF, Ades PA, Kligfield P, Arena R, Balady GJ, Bittner VA, Coke LA, Fleg JL,
Forman DE, Gerber TC et al: Exercise standards for testing and training: a scientific statement from the American
Heart Association. Circulation 2013, 128(8):873-934.
14.
Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD, Group ESCSD:
Fourth universal definition of myocardial infarction (2018). Eur Heart J 2018.
15.
Nordenfelt I, Adolfsson L, Nilsson JE, Olsson S: Reference values for exercise tests with continuous increase in load. Clin Physiol 1985, 5(2):161-172.
16.
Brudin L, Jorfeldt L, Pahlm O: Comparison of two commonly used reference materials for exercise bicycle tests with
a Swedish clinical database of patients with normal outcome. Clin Physiol Funct Imaging 2014, 34(4):297-307.
17.
Borg G, Ljunggren G, Ceci R: The increase of perceived exertion, aches and pain in the legs, heart rate and blood
lactate during exercise on a bicycle ergometer. Eur J Appl Physiol Occup Physiol 1985, 54(4):343-349.
18.
Banerjee A, Newman DR, Van den Bruel A, Heneghan C: Diagnostic accuracy of exercise stress testing for coronary artery disease: a systematic
review and meta-analysis of prospective studies. Int J Clin Pract 2012, 66(5):477-492.
19.
Enbergs A, Burger R, Reinecke H, Borggrefe M, Breithardt G, Kerber S: Prevalence of coronary artery disease in a general population without suspicion of
coronary artery disease: angiographic analysis of subjects aged 40 to 70 years referred
for catheter ablation therapy. Eur Heart J 2000, 21(1):45-52.
20.
Brzezinski RY, Fisher E, Ehrenwald M, Shefer G, Stern N, Shapira I, Zeltser D, Berliner
S, Shenhar-Tsarfaty S, Milwidsky A et al: Elevated high-sensitive troponin T in negative stress test individuals. Eur J Clin Invest 2018, 48(6):e12930.
21.
Alpert JS, Thygesen KA, White HD, Jaffe AS: Diagnostic and therapeutic implications of type 2 myocardial infarction: review and
commentary. Am J Med 2014, 127(2):105-108.
22.
Chapman AR, Adamson PD, Mills NL: Assessment and classification of patients with myocardial injury and infarction in
clinical practice. Heart 2017, 103(1):10-18.
23.
de Lemos JA: Increasingly sensitive assays for cardiac troponins: a review. JAMA 2013, 309(21):2262-2269.
24.
Holzmann MJ: Clinical implications of high-sensitivity cardiac troponins. J Intern Med 2018, 284(1):50-60.
25.
Costabel JP, Urdapilleta M, Lambardi F, Campos R, Vergara JM, Ariznavarreta P, Trivi
M: High-Sensitivity Cardiac Troponin Levels in Supraventricular Tachyarrhythmias. Pacing Clin Electrophysiol 2016, 39(6):588-591.
26.
Parwani AS, Boldt LH, Huemer M, Wutzler A, Blaschke D, Rolf S, Mockel M, Haverkamp
W: Atrial fibrillation-induced cardiac troponin I release. Int J Cardiol 2013, 168(3):2734-2737.
27.
Conti A, Angeli E, Scorpiniti M, Alesi A, Trausi F, Lazzeretti D, Padeletti L, Gensini
GF: Coronary atherosclerosis and adverse outcomes in patients with recent-onset atrial
fibrillation and troponin rise. The American journal of emergency medicine 2015, 33(10):1407-1413.
28.
Alghamry A, Hanna J, Pelecanos A, Kyranis S, Khelgi V, O'Rourke P, Carroll O, Oxenford
C, Rangaswamaiah S, Tan C: Predictors of significant coronary artery disease in atrial fibrillation: Are cardiac
troponins a useful measure. Int J Cardiol 2016, 223:744-749.
29.
Saunders JT, Nambi V, de Lemos JA, Chambless LE, Virani SS, Boerwinkle E, Hoogeveen
RC, Liu X, Astor BC, Mosley TH et al: Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease,
heart failure, and mortality in the Atherosclerosis Risk in Communities Study. Circulation 2011, 123(13):1367-1376.
30.
de Lemos JA, Drazner MH, Omland T, Ayers CR, Khera A, Rohatgi A, Hashim I, Berry JD,
Das SR, Morrow DA et al: Association of troponin T detected with a highly sensitive assay and cardiac structure
and mortality risk in the general population. JAMA 2010, 304(22):2503-2512.
31.
deFilippi CR, de Lemos JA, Christenson RH, Gottdiener JS, Kop WJ, Zhan M, Seliger
SL: Association of serial measures of cardiac troponin T using a sensitive assay with
incident heart failure and cardiovascular mortality in older adults. JAMA 2010, 304(22):2494-2502.
32.
Hijazi Z, Oldgren J, Andersson U, Connolly SJ, Ezekowitz MD, Hohnloser SH, Reilly
PA, Vinereanu D, Siegbahn A, Yusuf S et al: Cardiac biomarkers are associated with an increased risk of stroke and death in patients
with atrial fibrillation: a Randomized Evaluation of Long-term Anticoagulation Therapy
(RE-LY) substudy. Circulation 2012, 125(13):1605-1616.
33.
Hijazi Z, Wallentin L, Siegbahn A, Andersson U, Alexander JH, Atar D, Gersh BJ, Hanna
M, Harjola VP, Horowitz JD et al: High-sensitivity troponin T and risk stratification in patients with atrial fibrillation
during treatment with apixaban or warfarin. J Am Coll Cardiol 2014, 63(1):52-61.
34.
Gresslien T, Agewall S: Troponin and exercise. Int J Cardiol 2016, 221:609-621.
35.
Turer AT, Addo TA, Martin JL, Sabatine MS, Lewis GD, Gerszten RE, Keeley EC, Cigarroa
JE, Lange RA, Hillis LD et al: Myocardial ischemia induced by rapid atrial pacing causes troponin T release detectable
by a highly sensitive assay: insights from a coronary sinus sampling study. J Am Coll Cardiol 2011, 57(24):2398-2405.
36.
Thelin J, Melander O: Dynamic high-sensitivity troponin elevations in atrial fibrillation patients might
not be associated with significant coronary artery disease. BMC Cardiovasc Disord 2017, 17(1):169.
37.
Task Force M, Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A,
Bugiardini R, Crea F, Cuisset T et al: 2013 ESC guidelines on the management of stable coronary artery disease: the Task
Force on the management of stable coronary artery disease of the European Society
of Cardiology. Eur Heart J 2013, 34(38):2949-3003.
38.
Miller TD: Stress testing: the case for the standard treadmill test. Curr Opin Cardiol 2011, 26(5):363-369.